| Primary |
| Drug Use For Unknown Indication |
22.8% |
| Schizophrenia |
20.0% |
| Product Used For Unknown Indication |
18.8% |
| Bipolar Disorder |
8.9% |
| Schizophrenia, Paranoid Type |
4.6% |
| Schizoaffective Disorder |
4.2% |
| Psychotic Disorder |
4.0% |
| Depression |
3.6% |
| Anxiety |
2.4% |
| Hypertension |
1.3% |
| Insomnia |
1.3% |
| Diabetes Mellitus |
1.2% |
| Bipolar I Disorder |
1.1% |
| Affective Disorder |
1.0% |
| Ill-defined Disorder |
0.9% |
| Attention Deficit/hyperactivity Disorder |
0.9% |
| Sleep Disorder |
0.8% |
| Schizophrenia, Disorganised Type |
0.8% |
| Constipation |
0.7% |
| Drug Therapy |
0.7% |
|
| Weight Increased |
16.2% |
| Galactorrhoea |
10.9% |
| Tremor |
7.0% |
| Extrapyramidal Disorder |
5.1% |
| Tardive Dyskinesia |
5.1% |
| Dystonia |
4.9% |
| Suicide Attempt |
4.7% |
| Drug Ineffective |
4.6% |
| Tachycardia |
4.4% |
| Somnolence |
4.2% |
| Blood Prolactin Increased |
4.1% |
| Wrong Technique In Drug Usage Process |
3.7% |
| Rash |
3.6% |
| Neuroleptic Malignant Syndrome |
3.4% |
| Vomiting |
3.3% |
| Psychotic Disorder |
3.2% |
| Restlessness |
3.0% |
| Treatment Noncompliance |
2.9% |
| Sedation |
2.8% |
| Suicidal Ideation |
2.8% |
|
| Secondary |
| Schizophrenia |
21.5% |
| Product Used For Unknown Indication |
15.7% |
| Bipolar Disorder |
9.9% |
| Schizophrenia, Paranoid Type |
9.1% |
| Drug Use For Unknown Indication |
7.1% |
| Psychotic Disorder |
6.5% |
| Schizoaffective Disorder |
5.4% |
| Depression |
4.5% |
| Schizophrenia, Undifferentiated Type |
2.9% |
| Anxiety |
2.8% |
| Agitation |
2.1% |
| Constipation |
1.6% |
| Prophylaxis |
1.5% |
| Attention Deficit/hyperactivity Disorder |
1.5% |
| Insomnia |
1.5% |
| Abnormal Behaviour |
1.4% |
| Schizophrenia, Disorganised Type |
1.4% |
| Diabetes Mellitus |
1.3% |
| Personality Disorder |
1.3% |
| Hypertension |
1.2% |
|
| Weight Increased |
19.6% |
| Galactorrhoea |
7.4% |
| Tremor |
6.3% |
| Drug Ineffective |
5.2% |
| Weight Decreased |
5.1% |
| Extrapyramidal Disorder |
4.8% |
| Tardive Dyskinesia |
4.7% |
| Off Label Use |
4.5% |
| Agitation |
4.4% |
| Sedation |
4.1% |
| Neuroleptic Malignant Syndrome |
3.8% |
| Psychotic Disorder |
3.8% |
| Treatment Noncompliance |
3.7% |
| Oedema Peripheral |
3.6% |
| Suicide Attempt |
3.6% |
| Hyperprolactinaemia |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
| Somnolence |
3.0% |
| Schizophrenia |
2.9% |
| Tachycardia |
2.9% |
|
| Concomitant |
| Schizophrenia |
21.4% |
| Product Used For Unknown Indication |
18.5% |
| Bipolar Disorder |
11.0% |
| Depression |
8.5% |
| Schizoaffective Disorder |
6.5% |
| Anxiety |
4.9% |
| Psychotic Disorder |
3.1% |
| Hepatitis C |
2.7% |
| Drug Use For Unknown Indication |
2.5% |
| Affective Disorder |
2.4% |
| Hypertension |
2.3% |
| Pain |
2.3% |
| Schizophrenia, Paranoid Type |
2.3% |
| Agitation |
1.8% |
| Attention Deficit/hyperactivity Disorder |
1.7% |
| Crohn's Disease |
1.7% |
| Insomnia |
1.7% |
| Bipolar I Disorder |
1.6% |
| Asthma |
1.5% |
| Diabetes Mellitus |
1.4% |
|
| Weight Increased |
20.3% |
| Schizophrenia |
7.0% |
| Drug Ineffective |
5.9% |
| Off Label Use |
5.9% |
| Vomiting |
5.9% |
| Suicidal Ideation |
4.8% |
| Type 2 Diabetes Mellitus |
4.8% |
| Granulocytopenia |
4.3% |
| Psychotic Disorder |
4.3% |
| Delirium |
3.7% |
| Depression |
3.7% |
| Drug Dose Omission |
3.7% |
| Psychiatric Symptom |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Inappropriate Schedule Of Drug Administration |
3.2% |
| Incorrect Dose Administered |
3.2% |
| Leukopenia |
3.2% |
| Rash |
3.2% |
| Anxiety |
2.7% |
| Drug Interaction |
2.7% |
|
| Interacting |
| Hepatitis C |
39.1% |
| Schizophrenia |
26.1% |
| Drug Therapy |
13.0% |
| Schizoaffective Disorder |
8.7% |
| Bipolar Disorder |
4.3% |
| Chronic Myeloid Leukaemia |
4.3% |
| Product Used For Unknown Indication |
4.3% |
|
| Drug Interaction |
30.0% |
| Syncope |
20.0% |
| Aspiration Bronchial |
10.0% |
| Dehydration |
10.0% |
| Insomnia |
10.0% |
| Labelled Drug-food Interaction Medication Error |
10.0% |
| Mania |
10.0% |
|
